{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:24:46Z","timestamp":1778009086247,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejpb.2024.114315","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:34:36Z","timestamp":1716392076000},"page":"114315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel erythrocyte-shaped electrosprayed nanoparticles for co-delivery of paclitaxel and osimertinib: Preparation, characterization, and evaluation"],"prefix":"10.1016","volume":"200","author":[{"given":"Lirong","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3115-2210","authenticated-orcid":false,"given":"Zhepeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114315_b0005","doi-asserted-by":"crossref","first-page":"e12867","DOI":"10.1111\/cpr.12867","article-title":"Effects of propofol on the development of cancer in humans","volume":"53","author":"Xu","year":"2020","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.ejpb.2024.114315_b0010","series-title":"International Agency for Research on Cancer, in Encyclopedia of Toxicology (third Edition)","first-page":"1067","author":"Wild","year":"2014"},{"key":"10.1016\/j.ejpb.2024.114315_b0015","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.2147\/CMAR.S250632","article-title":"Current Therapeutic Progress of CDK4\/6 Inhibitors in Breast Cancer","volume":"12","author":"Wu","year":"2020","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.ejpb.2024.114315_b0020","doi-asserted-by":"crossref","first-page":"9605439","DOI":"10.1155\/2022\/9605439","article-title":"Global increase in breast cancer incidence: risk factors and preventive measures","volume":"2022","author":"Kashyap","year":"2022","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2024.114315_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2021.05.018","article-title":"Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy","volume":"335","author":"Hussain","year":"2021","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2024.114315_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2022.05.019","article-title":"A biotin-modified and H2O2-activatable theranostic nanoplatform for enhanced photothermal and chemical combination cancer therapy","volume":"177","author":"Jian","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.12.034","article-title":"Nanomedicines accessible in the market for clinical interventions","volume":"330","author":"Gadekar","year":"2021","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2024.114315_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2019.02.009","article-title":"Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment","volume":"137","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0045","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/cancers3033610","article-title":"Strategies to assess hypoxic\/HIF-1-active cancer cells for the development of innovative radiation therapy","volume":"3","author":"Yeom","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2024.114315_b0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cancers12040851","article-title":"Attenuation of the hypoxia inducible factor pathway after oncolytic adenovirus infection coincides with decreased vessel perfusion","volume":"12","author":"Yousaf","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2024.114315_b0055","doi-asserted-by":"crossref","first-page":"21495","DOI":"10.1073\/pnas.0907127106","article-title":"Red blood cell-mimicking synthetic biomaterial particles","volume":"106","author":"Doshi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejpb.2024.114315_b0060","doi-asserted-by":"crossref","first-page":"21485","DOI":"10.1021\/acsami.7b05580","article-title":"Tri-needle coaxial electrospray engineering of magnetic polymer yolk-shell particles possessing dual-imaging modality, multiagent compartments, and trigger release potential","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2024.114315_b0065","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1039\/D0BM01313G","article-title":"Structured micro\/nano materials synthesized via electrospray: a review","volume":"8","author":"He","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2024.114315_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122560","article-title":"Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity","volume":"632","author":"Hu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0075","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ajog.2022.12.009","article-title":"Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study","volume":"228","author":"Frumovitz","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejpb.2024.114315_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2023.09.014","article-title":"Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer","volume":"192","author":"Silli","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2023.01.010","article-title":"Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical Cancer: a NRG oncology randomized study","volume":"171","author":"Tewari","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejpb.2024.114315_b0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/nnm-2023-0015","article-title":"P-glycoprotein antibody-conjugated paclitaxel liposomes targeted for multidrug-resistant lung cancer","volume":"18","author":"Wang","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114315_b0095","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.3390\/ijms131216624","article-title":"Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure","volume":"13","author":"Melguizo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2024.114315_b0100","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.21037\/jtd.2019.08.32","article-title":"Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors","volume":"12","author":"Chen","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejpb.2024.114315_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2015.01.051","article-title":"Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation","volume":"481","author":"Danhier","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lungcan.2017.07.002","article-title":"Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib","volume":"111","author":"Oztan","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejpb.2024.114315_b0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/BCTT.S211030","article-title":"Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy-apoptosis crosstalk pathway","volume":"11","author":"Fleisher","year":"2019","journal-title":"Breast Cancer-Targets Therapy"},{"key":"10.1016\/j.ejpb.2024.114315_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.630256","article-title":"Case report: outcome of osimertinib treatment in lung adenocarcinoma patients with acquired KRAS mutations","volume":"11","author":"Xiu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejpb.2024.114315_b0125","doi-asserted-by":"crossref","first-page":"1600693","DOI":"10.1002\/biot.201600693","article-title":"The fabrication of iron oxide nanoparticle-nanofiber composites by electrospinning and their applications in tissue engineering","volume":"12","author":"Mortimer","year":"2017","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ejpb.2024.114315_b0130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/1567201819666220525095844","article-title":"Electrospun beads-on-the-string nanoproducts: preparation and drug delivery application","volume":"20","author":"Chen","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114315_b0135","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/polym15102237","article-title":"Engineered shellac beads-on-the-string fibers using triaxial electrospinning for improved colon-targeted drug delivery","volume":"15","author":"Yang","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2024.114315_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110432","article-title":"Core-sheath gelatin based electrospun nanofibers for dual delivery release of biomolecules and therapeutics","volume":"108","author":"Zandi","year":"2020","journal-title":"Mat. Sci. Eng. C-Mater."},{"key":"10.1016\/j.ejpb.2024.114315_b0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jaerosci.2018.04.008","article-title":"Electrosprays in the cone-jet mode: From Taylor cone formation to spray development","volume":"125","author":"Rosell-Llompart","year":"2018","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ejpb.2024.114315_b0150","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jconrel.2021.08.049","article-title":"Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy","volume":"338","author":"Xu","year":"2021","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2024.114315_b0155","first-page":"1967","article-title":"Electrosprayed core-shell solid dispersions of acyclovir fabricated using an epoxy-coated concentric spray head","volume":"9","author":"Liu","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114315_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1615\/AtomizSpr.2017019439","article-title":"Production of polymer microparticles by electrospray atomization","volume":"27","author":"Sander","year":"2017","journal-title":"At. Sprays"},{"key":"10.1016\/j.ejpb.2024.114315_b0165","article-title":"Extraction of malva sylvestris seed oil by soxhlet method and alginate\/chitosan microencapsulation with a new method: Investigation of its cytotoxic effects on human neuroblastoma cell line (SH-SY5Y)","volume":"17","author":"Ulusal","year":"2024","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"10.1016\/j.ejpb.2024.114315_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejpb.2024.114315_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.110850","article-title":"Application advance of electrosprayed micro\/nanoparticles based on natural or synthetic polymers for drug delivery system","volume":"220","author":"Zhao","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.ejpb.2024.114315_b0180","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1049\/iet-nbt.2018.0044","article-title":"Fabrication of cellulose nanoparticles through electrospraying","volume":"12","author":"Kadivar","year":"2018","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2024.114315_b0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2012.12.037","article-title":"Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration","volume":"443","author":"Nath","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114315_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jfb11010004","article-title":"Fabrication of polymeric microparticles by electrospray: the impact of experimental parameters","volume":"11","author":"Morais","year":"2020","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ejpb.2024.114315_b0195","first-page":"209","article-title":"Electrospray method: processing parameters influence on morphology and size of PCL particles","volume":"55","author":"Vu","year":"2017","journal-title":"Vietnam J. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114315_b0200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.fbp.2019.07.008","article-title":"Encapsulation of phycocyanin by electrospraying: A promising approach for the protection of sensitive compounds","volume":"119","author":"Schmatz","year":"2020","journal-title":"Food Bioprod. Process."},{"key":"10.1016\/j.ejpb.2024.114315_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020097","article-title":"Freeze-dried Lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations","volume":"11","author":"Khan","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114315_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104396","article-title":"The alleviation of lipid deposition in steatosis hepatocytes by capsaicin-loaded \u03b1-lactalbumin nanomicelles via promoted endocytosis and synergetic multiple signaling pathways","volume":"79","author":"Zuo","year":"2021","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ejpb.2024.114315_b0215","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2024.114315_b0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ctrv.2012.08.004","article-title":"New strategies for targeting the hypoxic tumour microenvironment in breast cancer","volume":"39","author":"Ward","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ejpb.2024.114315_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114870","article-title":"Ginsenoside Rb1 stabilized and paclitaxel \/ protopanaxadiol co-loaded nanoparticles for synergistic treatment of breast tumor","volume":"163","author":"Lu","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T05:54:29Z","timestamp":1718603669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"alternative-id":["S0939641124001413"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114315","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel erythrocyte-shaped electrosprayed nanoparticles for co-delivery of paclitaxel and osimertinib: Preparation, characterization, and evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114315"}}